CAS: 1394076-92-6
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
5-(6-(3-Methoxyoxetan-3-yl)-4-Morpholinothieno[3,2-d]pyriMidin-2-yl)pyriMidin-2-aMine REF: AN-AG009CI2CAS: 1394076-92-6 | 98% | 148.00 €~709.00 € | Fri 03 May 24 | |
GNE-317 REF: TM-T6845CAS: 1394076-92-6 | 99.42% | 39.00 €~623.00 € | Fri 10 May 24 | |
GNE-317 REF: 3D-UFC07692CAS: 1394076-92-6 | Min. 95% | To inquire | Fri 14 Jun 24 |
5-(6-(3-Methoxyoxetan-3-yl)-4-Morpholinothieno[3,2-d]pyriMidin-2-yl)pyriMidin-2-aMine
CAS:1394076-92-6
Formula:
C19H22N6O3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
414.4814
Ref: AN-AG009CI2
5mg | 148.00 € | |
10mg | 151.00 € | |
25mg | 298.00 € | |
50mg | 638.00 € | |
100mg | 709.00 € |
Estimated delivery in United States, on Friday 3 May 2024
GNE-317
CAS:1394076-92-6
GNE-317, a PI3K/mTOR inhibitor, can pass through the blood-brain barrier (BBB).
Formula:
C19H22N6O3S
Purity:
99.42%
Color and Shape:
Solid
Molecular weight:
414.48
Ref: TM-T6845
1mg | 39.00 € | |
2mg | 51.00 € | |
5mg | 82.00 € | |
10mg | 118.00 € | |
25mg | 207.00 € | |
50mg | 342.00 € | |
100mg | 426.00 € | |
200mg | 623.00 € | |
1ml*10 (DMSO) | 90.00 € |
Estimated delivery in United States, on Friday 10 May 2024
GNE-317
CAS:1394076-92-6
GNE-317 is a cancer therapeutic that inhibits the activity of CDK4/6 and is currently in …
Formula:
C19H22N6O3S
Purity:
Min. 95%
Molecular weight:
414.48 g/mol
Ref: 3D-UFC07692
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Friday 14 Jun 2024